BL

Blair T. Lapointe

Merck: 18 patents #575 of 9,382Top 7%
LY Lycera: 6 patents #12 of 35Top 35%
Overall (All Time): #254,065 of 4,157,543Top 7%
18
Patents All Time

Issued Patents All Time

Patent #TitleCo-InventorsDate
11174248 Indazolyl-spiro[2.3]hexane-carbonitrile derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof John J. Acton, III, David A. Candito, J. Michael Ellis, Peter H. Fuller, Hakan Gunaydin +6 more 2021-11-16
11161854 Indazolyl-spiro[2.2]pentane-carbonitrile derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof David A. Candito, Thomas H. Graham, John J. Acton, III, Ryan Chau, Joanna L. Chen +13 more 2021-11-02
10745364 Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease Thomas D. Aicher, Chad A. VanHuis, William D. Thomas, John MacLean, Brian M. Andresen +9 more 2020-08-18
10689369 Substituted indazole compounds as RORgammaT inhibitors and uses thereof Peter H. Fuller, Hakan Gunaydin, Kun Liu, Mark E. Scott, B. Wesley Trotter +1 more 2020-06-23
10584121 Heteroaryl substituted benzoic acids as RORgammaT inhibitors and uses thereof Hongjun Zhang, Kenneth J. Barr, Hakan Gunaydin, Kun Liu, B. Wesley Trotter 2020-03-10
10377768 Tetrahydronaphthyridine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease Thomas D. Aicher, Kenneth J. Barr, Vladimir Simov, Karin Ann Stein, William D. Thomas +3 more 2019-08-13
10344000 Substituted bicyclic pyrazole compounds as RORgammaT inhibitors and uses thereof Peter H. Fuller, Hakan Gunaydin, Kun Liu, Danielle F. Molinari, Qinglin Pu +3 more 2019-07-09
10287272 Substituted indazole compounds as RORgammaT inhibitors and uses thereof Peter H. Fuller, Hakan Gunaydin, Kun Liu, Mark E. Scott, B. Wesley Trotter +1 more 2019-05-14
10221142 Substituted pyrazole compounds as RORgammaT inhibitors and uses thereof Peter H. Fuller, Hakan Gunaydin, Kun Liu, Nunzio Sciammetta, Benjamin Wesley Trotter +5 more 2019-03-05
10221146 Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease Thomas D. Aicher, Chad A. VanHuis, William D. Thomas, John MacLean, Brian M. Andresen +9 more 2019-03-05
10196354 4-heteroaryl substituted benzoic acid compounds as RORgammaT inhibitors and uses thereof Kenneth J. Barr, Corey E. Bienstock, John MacLean, Hongjun Zhang, Richard Thomas Beresis +3 more 2019-02-05
9809561 Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease Thomas D. Aicher, Chad A. VanHuis, William D. Thomas, John MacLean, Brian M. Andresen +9 more 2017-11-07
9745265 4-heteroaryl substituted benzoic acid compounds as RORgammaT inhibitors and uses thereof Kenneth J. Barr, Corey E. Bienstock, John MacLean, Hongjun Zhang, Richard Thomas Beresis +3 more 2017-08-29
9663522 3-aminocycloalkyl compounds as RORgammaT inhibitors and uses thereof Kenneth J. Barr, John MacLean, Hongjun Zhang, Richard Thomas Beresis, Neville J. Anthony +2 more 2017-05-30
9663502 2-Acylamidomethyl and sulfonylamidomethyl benzoxazine carbamates for inhibition of RORgamma activity and the treatment of disease Thomas D. Aicher, Chad A. VanHuis, John MacLean, Brian M. Andresen, Kenneth J. Barr +9 more 2017-05-30
9657033 Tetrahydronaphthyridine and related bicyclic compounds for inhibition of RORγ activity and the treatment of disease Thomas D. Aicher, Kenneth J. Barr, Vladimir Simov, Karin Ann Stein, William D. Thomas +3 more 2017-05-23
9556168 N-alkylated indole and indazole compounds as RORgammaT inhibitors and uses thereof Kenneth J. Barr, Corey E. Bienstock, John MacLean, Hongjun Zhang, Richard Thomas Beresis +2 more 2017-01-31
9487490 3-cyclohexenyl and cyclohexyl substituted indole and indazole compounds as RORgammaT inhibitors and uses thereof Kenneth J. Barr, John MacLean, Hongjun Zhang, Richard Thomas Beresis, Dongshan Zhang +3 more 2016-11-08